Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Mefuvir Medicinal Technology is a specialized pharmaceutical company headquartered in Beijing, China, focusing on the development and industrialization of high-end drug delivery systems. The company's core expertise lies in complex formulations, specifically transdermal drug delivery systems (TDDS) and oral thin films (OTF). Mefuvir targets therapeutic areas with significant unmet needs, such as Alzheimer's disease, Parkinson's disease, and chronic pain, by developing improved versions of existing drugs to enhance patient compliance. In addition to its internal pipeline, the company offers comprehensive CRO and CDMO services for complex generics and 505(b)(2) drug development. Mefuvir maintains state-of-the-art R&D facilities and manufacturing lines that comply with international GMP standards.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Mefuvir Medicinal Technology.